← Back to Search

Video-Based HIV Test Information for Spanish-Speaking Latinos with HIV/AIDS

Phase 3
Waitlist Available
Led By Dr. Roland Merchant, MD, MPH, ScD
Research Sponsored by Rhode Island Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-64 years of age
Be between 18 and 65 years old
Must not have
Significant visual or hearing impairment
Being treated for acute psychiatric illness
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Pivotal Trial

Summary

This trial will test whether a video on HIV and HIV tests is as effective as an in-person presentation with an HIV test counselor in delivering information to Spanish-speaking HIV test recipients.

Who is the study for?
This trial is for Spanish-speaking Latinos aged 18-64 who can consent to participate. It's not suitable for those with severe visual or hearing impairments, prisoners, the critically ill, intoxicated individuals, those treated for acute psychiatric illnesses, mentally incapacitated persons, or participants in HIV vaccine trials.
What is being tested?
The study is testing if a video in Spanish about HIV and its testing methods is as effective as getting this information from an in-person counselor. Participants will receive either the video or live presentation.
What are the potential side effects?
Since this trial involves informational videos and presentations rather than medical treatments, there are no direct side effects associated with the interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 64 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have major issues with my sight or hearing.
Select...
I am currently receiving treatment for a sudden mental health issue.
Select...
I am mentally capable of making my own decisions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Video PresentationExperimental Treatment1 Intervention
Participants will watch an HIV and HIV testing video
Group II: In Person CounselingActive Control1 Intervention
Participants will receive an in person HIV and HIV testing counseling session

Find a Location

Who is running the clinical trial?

Rhode Island HospitalLead Sponsor
263 Previous Clinical Trials
68,595 Total Patients Enrolled
Dr. Roland Merchant, MD, MPH, ScDPrincipal InvestigatorRhode Island Hospital

Media Library

Video or In-Person Presentation Clinical Trial Eligibility Overview. Trial Name: NCT01452555 — Phase 3
HIV/AIDS Research Study Groups: In Person Counseling, Video Presentation
HIV/AIDS Clinical Trial 2023: Video or In-Person Presentation Highlights & Side Effects. Trial Name: NCT01452555 — Phase 3
Video or In-Person Presentation 2023 Treatment Timeline for Medical Study. Trial Name: NCT01452555 — Phase 3
~14 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top